SÖZ
ALTI
NEWS
Home
The day in news
This week
Archive
Crisis
About
EN
AZ
sözaltı
news
Finance
Finance
EN
AZ
Jim Cramer Weighs Amgen (AMGN) After Novartis Trial Failure
finance.yahoo.com
12.09.2026 12:48
4 views
Copy link
Save
Pick
Copy link
WhatsApp
Telegram
X
Reddit
Facebook
LinkedIn
Email
More
Image
Share image
Save
Copy link
Similar stories
2 outlets
See how this story developed, hour by hour
Amgen Falls 10% as Novartis Trial Failure Clouds a Cholesterol Drug Class; NVS Stock Drops 14%
finance.yahoo.com
08.09.2026
Why Novartis’ Drug Trial Results Are Blowing Up Amgen Stock
barrons.com
08.09.2026
Related stories
Will Micron Technology Stock Soar to $1,500 After Sept. 30?
finance.yahoo.com · 13.09
She Inherited Her Husband’s $300,000 IRA at 56 and Rolled It Into Her Own Name, Like the Bank Suggested. Every Withdrawal Until 59½ Cost Her a 10% Penalty She Didn’t Have to Pay
finance.yahoo.com · 13.09
Prediction: This Memory Stock Could Surge 233% Over the Next 3 Years (Hint: It's not Micron or Sandisk)
finance.yahoo.com · 13.09
Sept. 16 Will Provide a Clearer Path for Interest Rates -- These 3 High-Yield Dividend Stocks Win Either Way
finance.yahoo.com · 13.09
Ryanair CEO sends rattling message on airfares ahead of earnings
finance.yahoo.com · 13.09
3 of the Most Resilient High-Yield Dividend Stocks in the Chemical Sector: A Safety Deep Dive
finance.yahoo.com · 13.09
← Previous
Jim Cramer Discussed The Contradictions Surrounding NVIDIA Corporation (NASDAQ:NVDA)’s Shares
Next →
Jim Cramer Notes lululemon (LULU) is “Executing Really Poorly”